Shirakawa, T., Ueki, H., Kakei, Y., Hara, T., Teishima, J., Goto, K., Furukawa, J., Hinata, N., Miyake, H. (2025). Phase 1 study of B440, an oral
            <i>Bifidobacterium</i>
            -engineered WT1 cancer vaccine, in patients with metastatic urothelial cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2505